Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice

Neurobiology of Disease

Volumn 7, Issue 3, 2000, Pages 152-168

  Bronfman, Francisca C ^a   Moechars, Dieder ^a,b   Van Leuven, Fred ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Aging; Alzheimer's disease; Amyloid plaques; Cholinergic system; Transgenic mice models

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CELL AGING; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DEAFFERENTATION; DENTATE GYRUS; GENE OVEREXPRESSION; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE; TRANSGENIC MOUSE;

EID: 0034210750     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2000.0283     Document Type: Article

References (75)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:1946;239-247.
2. Alvarez A., Alarcón R., Opazo C., Campos E. O., Munos F. J., Calderón F. H., Dajas F., Gentry M. K., Doctor B. P., De Mello F. G., Inestrosa N. C. Stable complexes involving acetylcholinesterase and amyloid-β-peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J. Neurosci. 18:1998;3213-3223.
3. Araujo D. M., Lapchak P. A., Meaney M. J., Collier B., Quirion R. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: Relationship to presynaptic cholinergic markers and binding sites. J. Neurosci. 10:1990;3069-3078.
4. Arendt T., Brückner M., Lange M., Bigl V. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development- A study of molecular forms. Neurochem. Int. 21:1992;381-396.
5. Arendt T., Holzer M., Gertz H.-J., Brückner M. K. Cortical load of PHF-tau in Alzheimer's disease is correlated with cholinergic dysfunction. J. Neural. Transm. 106:1999;513-523.
6. Aubert I., Araujo D. M., Cécyre D., Robitaille Y., Gauthier S., Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's disease and Parkinson's disease. J. Neurochem. 58:1992;529-541.
7. Bales K. R., Verina T., Dodel R. C., Du Y., Altstiel L., Bender M., Hyslop P., Johnstones E. M., Little S. P., Cummins D. J., Piccardo P., Ghetti B., Paul S. M. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17:1997;263-2634.
8. Barelli H., Lebeau A., Vizzavona J., Chevallier N., Drout C., Marambaud P., Ancolio K., Buxbaum J. D., Khorkova O., Heroux J., Sahasrabudhe S., Martinez J., Warter J. M., Mohr M., Checler F. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol. Med. 3:1997;695-707.
9. Bierer L. M., Haroutunian V., Gabriel S., Knott P. J., Carlin L. S., Purohit D. P., Perl D. P., Schmeidler J., Kanof P., Davis K. L. Neurochemical correlates of dementia severity in Alzheimer's diasesae relative importance of the cholinergic system. J. Neurochem. 64:1995;749-760.
10. Bissette G., Seidler F. J., Nemeroff C. B., Slotkin T. A. High affinity choline transporter status in Alzheimer's disease tissue from rapid autopsy. Ann. N. Y. Acad. Sci. 777:1996;197-204.
11. Bobinski M., Wegiel J., Tarnawski M., Bobinski M., Reisberg B., De Leon M. J., Miller D. G., Wisniewski H. M. Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J. Neurophatol. Exp. Neurol. 56:1997;414-420.
12. Bradford M. M. A rapid and sensitive method for the quantification of micrograms quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-254.
13. Bronfman F. C., Fernandez H. L., Inestrosa N. C. Amyloid precursor protein fragment and acetylcholinesterase increase with cell confluence and differentiation in a neuronal cell line. Exp. Cell. Res. 229:1996;93-99.
14. Calhoun M. E., Wiederhold K-H., Abramowski D., Phinney A. L., Probst A., Sturchler-Pierrat C., Staufendield M., Sommer B., Jucker M. Neuron loss in APP transgenic mice. Nature. 395:1998;755-756.
15. Chen K. S., Nishimura M. C., Armanini M. P., Crowley C., Spencer S. D., Phillips H. S. Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits. J. Neurosci. 17:1997;7288-7296.
16. Commins S., Anderton M., Gigg J. The effects of the single and multiple episodes of theta patterned or high frequency stimulation on synaptic transmission from hippocampal area CA1 to the subiculum in rats. Neurosci. Lett. 270:1999;99-102.
17. Commins S., Gigg J., Anderson M., O'Mara S. M. The projection from hippocampal area CA1 to the subiculum sustains long-term potentiation. Neuroreport. 9:1998;847-850.
18. Cummings J. L., Kaufer D. Neuropsychiatric aspects of Alzheimer's disease: The cholinergic hypothesis revisited. Neurology. 47:1996;876-883.
19. Cuello A. C., Sofroniew M. V. The anatomy of the CNS cholinergic neurons. Trends Neurosci. 1984;74-78.
20. Davis K. L., Mohs R. C., Marin D., Purohit D. P., Perl D. P., Lantz M., Austin G., Haroutunian V. Cholinergic markers in elderly patients with early signs of Alzheimer's disease. JAMA. 281:1999;1401-1406.
21. Dutar P., Bassant M. H., Senut M. C., Lamour Y. The septohippocanpal pathway: Structure and function of a central cholinergic system. Physiol. Rev. 75:1995;393-427.
22. Ellman G. I., Courtney K. D., Andres V., Featherstones R. M. A new rapid colorimetric determination of cholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
23. Fagan A. M., Suhr S. T., Lucidi-Philippi C. A., Peterson D. A., Holtzman D. M., Gage F. H. Endogenous FGF-2 is important for cholinergic sprouting in the denevervated hippocampus. J. Neurosci. 17:1997;2499-2511.
24. Flood D. G. Region-specific stability of dendritic extent in normal human aging and regression in Alzheimer's disease. II. Subiculum. Brain. Res. 540:1991;83-95.
25. Fonnum F. A rapid radiochemical method for the determination of choline acetyl transferase. J. Neurochem. 24:1974;407-409.
26. Francis P. T., Palmer A. M., Wilcock G. The cholinergic hypothesis of Alzheimer's diasease: A review of progress. J. Neurol. Neurosurg. Psychiatry. 66:1999;137-147.
27. Franklin B. J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego.
28. Frautschy S. A., Yang F., Irrizarry M., Hyman B., Saido T. C., Hsiao K., Cole G. M. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152:1998;307-317.
29. Games D., Adams D., Alessandrini R., Barbour R., Zhao J. Alzheimer-type neurophatology in transgenic mice overexpressing V717F b-amyloid precursor protein. Nature. 373:1995;523-526.
30. Garofalo L., Cuello A. C. Nerve growth factor and the monosialoganglioside GM1: Analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats. Exp. Neurol. 125:1994;195-217.
31. Garofalo L., Ribeiro-Da-Silva A., Cuello A. C. Nerve growth factor-induced synaptogenesis and hypertrophy of cortical cholinergic terminal. Proc. Natl. Acad. Sci. USA. 89:1992;2639-2642.
32. Geddes J. W., Monaghan D. T., Cotman C. W., Lott I. T., Kim R. C., Chang Chui H. Plasticity of hippocampal circuitry in Alzheimer's disease. Science. 230:1985;1179-1181.
33. Geula C., Mesulam M. M., Saroff D. M., Wu C. K. Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer disease. J. Neuropathol. Exp. Neurol. 57:1998;63-75.
34. Geula C., Mesulam M. M. Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. Terry R. D., Kaltzman R., Bick K. L. Alzheimer Disease. 1994;263-291 Raven Press, New York.
35. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci. 16:1993;460-465.
36. Haass C., Selkoe D. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell. 75:1993;1039-1042.
37. 3H]hemicholinium-3. J. Comp. Neurol. 321:1992;591-611.
38. 3H]hemicholinium-3 as a quantitative marker. J. Neurochem. 60:1993;1191-1201.
39. Hellweg R., Humpel C., Löwe A., Hörtnagl H. Moderate lesion of the rat cholinergic septohippocampal pathway increases hippocampal nerve growth factor synthesis/evidence for long-term compensatory changes? Mol. Brain Res. 45:1997;177-181.
40. Higgins L. S., Rodems J. M., Quon C. D., Cordell B. Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for β-APP751. Proc. Natl. Acad. Sci. USA. 92:1995;4402-4406.
41. Hsia A. Y., Masliah E., McConlogue L., Gui-qiu Y., Tatsuno G., Hu K., Kholodenko D., Malenka R. C., Nicoll R. A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA. 96:1999;3228-3233.
42. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
43. Inestrosa N. C., Alvarez A., Pérez C. A., Moreno R. D., Vicente M., Linker C., Casanueva O. I., Soto C., Garrido J. Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme. Neuron. 16:1996;881-891.
44. Irizarry M. C., Soriano F., McNamara M., Page K. J., Schenk, Games D., Hyman B. T. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mice. J. Neurosci. 17:1997;7053-7059.
45. Irizarry M. C., McNamara M., Fedorchak K., Hsiao K., Hyman B. T. APPsw Transgenic Mice develop age-related Aβ deposits and neuropil abnormalities, but not neuronal loss in CA1. J. Neurophatol. Exp. Neurol. 56:1997;965-973.
46. Jucker M., Ingram D. K. Murine models of brain aging and age-related neurodegenerative diseases. Behav. Brain Res. 85:1997;1-25.
47. Karnovsky M. J., Roots L. A "direct coloring" thiocholine method for cholinesterases. J. Histochem. Cytochem. 12:1964;219-221.
48. Kitt C. A., Höhmann C., Coyle J. T., Price D. L. Cholinergic innervation of mouse forebrain structures. J. Comp. Neurol. 341:1994;117-129.
49. Koliatsos V. E., Price D. L., Gouras G. K., Cayouette M. H., Burton L. E., Winslow J. W. Highly selective effect of nerve growth factor, brain-derived neurotrophic factoy, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons. J. Comp. Neurol. 343:1994;247-262.
50. Kuhl D. E., Minoshima S., Fessler J. A., Frey K. A., Foster N. L., Ficaro E. P., Wieland D. M., Koeppe R. A. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann. Neurol. 40:1996;399-410.
51. McGeer P. L., McGeer E. G., Susuki J., Dolman C. E., Nagai T. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology. 34:1984;741-745.
52. Moechars D., Dewachter I., Lorent K., Reversé D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Van Den Haute C., Cordell B., Checler F., Godaux E., Van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274:1999;6483-6492.
53. Moechars D., Gilis M., Kuipéri C., Laenen I., Van Leuven F. Aggressive behavior in transgenic mice expressing APP is alleviated by serotonergic drugs. Neuroreport. 9:1998;3561-3564.
54. Moechars D., Lorent K., De Strooper D., Dewachter I., Van Leuven F. Expression in brain of amyloid precursor protein mutated in the α-secretase site cause disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO. J. 15:1996;1265-1274.
55. Morán M. A., Mufson E. J., Gómez-Ramos P. Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer's brains. Acta Neurophatol. 85:1984;362-369.
56. Parnetti L., Senin U., Mecocci P. Cognitive enhancement therapy for Alzheimer's disease. Drugs. 56:1997;752-768.
57. Pericak-Vance M. A., Haines J. L. Genetic susceptibility to Alzheimer disease. Trends Neurosci. 11:1995;504-508.
58. Perry E. K., Tomlinson B. E., Blessed G., Bergmann K., Gibson P. G., Perry R. H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2:1978;1457-1459.
59. Price D. L, Tanzi R. E., Borchelt D. R., Sisodia S. S. Alzheimer's disease: Genetic studies and transgenic models. Annu. Rev. Genet. 32:1998;461-493.
60. Procter A. W. Neurochemical correlates of dementia. Neurodegeneration. 5:1996;403-407.
61. Ransmayr G., Cervera P., Hirsch E., Ruberg M., Hersh L. B., Duyckaerts C., Hauw J. J., Delumeau C., Agid Y. Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer's disease. Neuroscience. 32:1989;701-714.
62. Rodrígues-Puertas R., Pascual J., Vilaró T., Pazos A. Autorradiographic distribution of M1, M2, M3 and M4 muscarinic receptor subtypes in Alzheimer's disease. Synapse. 26:1997;341-350.
63. Rosenthal H. E. A graphic method for the determination and representation of binding parameters in a complex system. Anal. Biochem. 20:1967;525-532.
64. Schenk F., Morris R. G. M. Dissociation between components of spatial memory in rats after recovery from the effects of retrohippocampal lesions. Exp. Brain. Res. 58:1985;11-28.
65. Saper C. B., German D. C., White C. L. Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type: Possible role in cell loss. Neurology. 35:1985;1089-1095.
66. Sberna G., Sáez-Valero J., Li Q. X., Czech C., Beyreuther K., Masters C. L., McLean C. A., Small D. H. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the β-amyloid protein precursor of Alzheimer's disease. J. Neurochem. 71:1998;723-731.
67. Sharp P. E., Green C. Spatial correlates of firing patterns of single cells in the subiculum of freely moving rat. J. Neurosci. 14:1994;2339-2356.
68. Stürchler-Pierrat C., Abramowski D., Duke M., Wiederhold K. H., Mistl C., Rothacher S., Ledermann B., Burki K., Frey P., Paganetti P. A., Waridel C., Calhoun M. E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer's disease-like pathology. Proc. Natl. Acad. Sci. USA. 94:1997;13287-13292.
69. Tago H., Kimura H., Maeda T. Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by sensitive histochemical procedure. J. Histochem. Cytochem. 34:1986;1431-1438.
70. Terry R. D. The pathogenesis of Alzheimer disease: An alternative to the amyloid hypothesis. J. Neurophatol. Exp. Neurol. 55:1996;1023-1025.
71. Vogels O. J. M., Broere C. A. J., Ter Laak H. J., Ten Donkelaar H. J., Nieuwenhuys R., Schulte B. P. M. Cell loss and shrinkage in the nucleus basalis of Meynert complex in Alzheimer's disease. Neurobiol. Aging. 11:1990;3-13.
72. Whitehouse P. J., Price D., Clark A. W., Coyle J. T., DeLong M. R. Alzheimer Disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10:1981;122-126.
73. Williams L. R., Varon S., Peterson G. M., Wictorin K., Fisher W., Bjorklund A., Gage F. H. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl. Acad. Sci. USA. 83:1986;9231-9235.
74. Willson C. A., Hanin I. Effect of nerve growth factor in ethylcholine mustard aziridinium (AF64A)-treated rats: Sensitization of cholinergic enzyme activity in the septohippocampal pathway. J. Neurochem. 65:1995;856-862.
75. Wong, T. P., Debeir, T., Duff, K., & Cuello, A. C.Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J. Neurosci.19, 2706-2719.